Patents by Inventor Brendan Manning

Brendan Manning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240026415
    Abstract: The invention features methods, panels, cartridges, and systems for detecting pathogens and for diagnosing and treating diseases, including bacteremia and sepsis.
    Type: Application
    Filed: October 25, 2022
    Publication date: January 25, 2024
    Inventors: Ulrich Hans THOMANN, Lori Anne NEELY, Heidi Susanne GIESE, Jessica Ann TOWNSEND, Rahul Krishan DHANDA, Thomas Jay LOWERY, JR., Urvi VED, Brendan MANNING, Nu Ai PHUNG, Joanne Lawton GARVER, Benjamin B. STONE
  • Patent number: 11519016
    Abstract: The invention features methods panels, cartridges, and systems for detecting pathogens and for diagnosing and treating diseases, including bacteremia and sepsis.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: December 6, 2022
    Assignee: T2 Biosystems, Inc.
    Inventors: Ulrich Hans Thomann, Lori Anne Neely, Heidi Susanne Giese, Jessica Ann Townsend, Rahul Krishan Dhanda, Thomas Jay Lowery, Jr., Urvi Ved, Brendan Manning, Nu Ai Phung, Joanne Lawton Garver, Benjamin B. Stone
  • Publication number: 20190071707
    Abstract: The invention features methods panels, cartridges, and systems for detecting pathogens and for diagnosing and treating diseases, including bacteremia and sepsis.
    Type: Application
    Filed: January 20, 2017
    Publication date: March 7, 2019
    Inventors: Ulrich Hans THOMANN, Lori Anne NEELY, Heidi Susanne GIESE, Jessica Ann TOWNSEND, Rahul Krishan DHANDA, Thomas Jay LOWERY, Jr., Urvi VED, Brendan MANNING, Nu Ai PHUNG, Joanne Lawton GARVER, Benjamin B. STONE
  • Publication number: 20180179524
    Abstract: The present disclosure provides, among other things, compounds that inhibit the expression or activity of gene products having a synthetic lethal interaction with loss of TSC1 and/or TSC2. Also provided are applications, such as therapeutic and diagnostic methods, in which the compounds are useful. For example, the compounds described herein can be used in methods for treating a proliferative disorder (e.g., a cancer) or an inflammatory disorder.
    Type: Application
    Filed: March 4, 2016
    Publication date: June 28, 2018
    Inventors: Norbert Perrimon, Benjamin Housden, Alexander Valvezan, Brendan Manning